Federal Funding Opportunities August 2023

• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (PA-23-189) Office of the Director, NIH Centers for Disease Control and Prevention John E. Fogarty International Center National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Institute for Occupational Safety and Health National Library of Medicine Office of Behavioral and Social Sciences Research Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Office of Research on Women’s Health Application Receipt Date(s): Due dates vary by awarding IC. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) (PAR-23-200) National Eye Institute Application Receipt Date(s): March 16, 2025
• NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed) (PAR-23-205) National Eye Institute Application Receipt Date(s): March 16, 2025
• Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) (PAR-23-215) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of Mental Health Application Receipt Date(s): September 07, 2025
• HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) (PAR-23-225) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs National Institute of Allergy and Infectious Diseases National Institute of Mental Health Application Receipt Date(s): September 07, 2025
• Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed) (PAR-23-234) National Institute of Mental Health Application Receipt Date(s): August 24, 2023
• Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) (PAR-24-023) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement.
• Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) (PAR-24-024) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement.
• Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) (PAR-24-025) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement.
• Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) (PAR-24-026) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement.
• Advancing Development of Diagnostics for Congenital and Adult Acquired Syphilis (R21 Clinical Trial Not Allowed) (RFA-AI-23-039) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): November 02, 2023
• Limited Competition: NIH-DoD-VA Pain Management Collaboratory – Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-AT-24-002) National Center for Complementary and Integrative Health National Institute on Alcohol Abuse and Alcoholism National Institute of Nursing Research Office of Disease Prevention Application Receipt Date(s): August 31, 2023
• Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional) (RFA-CA-23-026) National Cancer Institute Application Receipt Date(s): September 14, 2023
• Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional) (RFA-CA-23-027) National Cancer Institute Application Receipt Date(s): September 14, 2023
• Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed) (RFA-MH-24-100) National Institute of Mental Health Application Receipt Date(s): Not Applicable
• Optimization of Genome Editing Therapeutics for Alzheimer’s Disease-Related Dementias (ADRD) (U01 – Clinical Trials Not Allowed) (RFA-NS-24-009) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): September 06, 2023
• Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 – Clinical Trial Not Allowed) (RFA-NS-24-025) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): November 08, 2023
• PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-23-230) National Institutes of Health National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Center for Environmental Health National Cancer Institute National Center for Injury Prevention and Control National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Institute for Occupational Safety and Health National Library of Medicine Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): Multiple dates, see announcement.
• PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) (PA-23-232) National Institutes of Health National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Library of Medicine Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) – Transitional Centers (P30 Clinical Trial Optional) (PAR-23-216) National Institute of General Medical Sciences Application Receipt Date(s): Multiple dates, see announcement.
• SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) (PAR-23-219) Office of the Director, NIH National Center for Advancing Translational Sciences National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Application Receipt Date(s): Multiple dates, see announcement.
• Research Resource for Systematic Reviews of Complementary and Integrative Health (R24 Clinical Trial Not Allowed) (RFA-AT-24-005) National Center for Complementary and Integrative Health Application Receipt Date(s): August 31, 2023
• Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed) (RFA-DK-22-512) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): October 19, 2023
• Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-DK-22-513) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): October 19, 2023
• Single Source: NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed) (RFA-EB-23-007) National Institute of Biomedical Imaging and Bioengineering National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Office of Behavioral and Social Sciences Research Application Receipt Date(s): September 26, 2023
• Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Research Centers (U01 Clinical Trial Not Allowed) (RFA-HL-24-006) National Heart, Lung, and Blood Institute Application Receipt Date(s): October 27, 2023
• Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Data Coordinating Center (U24- Clinical Trial Not Allowed) (RFA-HL-24-007) National Heart, Lung, and Blood Institute Application Receipt Date(s): October 27, 2023
• Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Human Tissue Core (U01- Clinical Trial Not Allowed) (RFA-HL-24-012) National Heart, Lung, and Blood Institute Application Receipt Date(s): October 27, 2023
• Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical Trial Data Processing, Analysis, and Coordination Center (U24 Clinical Trial Not Allowed) (RFA-MH-24-151) National Institute of Mental Health Application Receipt Date(s): October 17, 2023
• Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed) (RFA-RM-23-013) Office of Strategic Coordination (Common Fund) Application Receipt Date(s): December 04, 2023
• Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
  (PAR-23-238)
  National Institute of Mental Health
  Application Receipt Date(s): September 07, 2026
• Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
  (PAR-23-239)
  National Institute of Mental Health
  Application Receipt Date(s): September 07, 2026
• Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
  (PAR-23-246)
  National Cancer Institute
  Application Receipt Date(s): May 04, 2026
• Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
  (RFA-AG-24-050)
  National Institute on Aging
  Application Receipt Date(s): October 31, 2023
• Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
  (RFA-CA-23-036)
  National Cancer Institute
  Application Receipt Date(s): November 15, 2023
• Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
  (RFA-CA-23-037)
  National Cancer Institute
  Application Receipt Date(s): November 15, 2023
• HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
  (RFA-DA-24-063)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): February 01, 2024
• HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
  (RFA-DA-24-064)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): February 01, 2024
• Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
  (RFA-DA-25-014)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 14, 2025
• Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
  (RFA-DA-25-020)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 19, 2025
• The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R01 Clinical Trial Optional)
  (RFA-HL-24-008)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 11, 2023
• The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R34 Clinical Trial Optional)
  (RFA-HL-24-009)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 11, 2023
• NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
  (RFA-NS-24-014)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): February 10, 2025
• National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
  (PAR-23-235)
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Role of Environmental Stress in the Health Inequities of Alzheimer’s Disease-Related Dementias (ADRD) (R01 – Clinical Trial Not Allowed)
  (RFA-NS-24-024)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): November 01, 2023
• Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
  (RFA-RM-23-015)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): November 17, 2023

• RFA-AG-24-037: Limited Competition: National Health and Aging Trends (NHATS) and National Study of Caregiving (NSOC) (U01 Clinical Trial Not Allowed)
• RFA-AG-24-047: Grants for Early Medical/Surgical Specialists’ Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
• RFA-AG-24-025: Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional)
• RFA-AG-24-026: Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)